Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target of $42.00. The company’s shares closed yesterday ...

As Carlo Buontempo (Rome, 52 years old), director of the Copernicus Climate Change Service — the European Union’s Earth observation program — points out, the main bodies that monitor the world’s ...

In a report released yesterday, J. Bruce Chan from Stifel Nicolaus maintained a Buy rating on ArcBest (ARCB – Research Report), with a price target of $109.00. The company’s shares closed ...

Last year’s global average temperature easily passed 2023′s record heat and kept pushing even higher. It surpassed the long-term warming limit of 1.5 degrees Celsius (2.7 degrees Fahrenheit) since the ...

This year’s crop of newly public artistic creations lacks the landmark vibes of last year’s entrance of Mickey Mouse into the public domain. But they include a deep well of canonical works ...

What should I know about this firm? Stifel, Nicolaus & Co. Inc. offers investment advising services that let individuals choose the level of control they have over their portfolio. Everyday ...